The increase in product revenue was primarily due to an increase in demand for LifeCell's flagship reconstructive surgical product, AlloDerm (R) Regenerative Tissue Matrix, which increased 30% to ...
Co announces it received 510(k) clearance from the FDA for Strattice tissue matrix, a novel soft tissue repair product. Like AlloDerm, the co's flagship reconstructive surgical product, Strattice is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results